| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |